Simplex Trading
SRPT icon

Simplex Trading’s Sarepta Therapeutics SRPT Stock Holding History

Simplex Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.39M Sell
339,700
-42,100
-11% -$815K 0.01% 844
2025
Q4 		$8.22M Sell
381,800
-78,100
-17% -$1.65M ﹤0.01% 970
2025
Q3 		$8.86M Buy
459,900
+290,500
+171% +$5.18M ﹤0.01% 1048
2025
Q2 		$2.9M Buy
169,400
+143,200
+547% +$6.11M ﹤0.01% 1787
2025
Q1 		$1.67M Sell
26,200
-12,800
-33% -$1.35M ﹤0.01% 2209
2024
Q4 		$4.74M Sell
39,000
-6,700
-15% -$821K ﹤0.01% 1509
2024
Q3 		$5.71M Sell
45,700
-91,300
-67% -$12.6M ﹤0.01% 1401
2024
Q2 		$21.6M Buy
137,000
+23,000
+20% +$2.95M 0.01% 581
2024
Q1 		$14.8M Sell
114,000
-187,200
-62% -$22.9M 0.01% 890
2023
Q4 		$29M Sell
301,200
-29,400
-9% -$2.82M 0.02% 547
2023
Q3 		$40.1M Buy
330,600
+20,300
+7% +$2.29M 0.03% 344
2023
Q2 		$35.5M Buy
310,300
+106,000
+52% +$13.7M 0.03% 356
2023
Q1 		$28.2M Buy
204,300
+171,900
+531% +$22.3M 0.02% 446
2022
Q4 		$4.2M Buy
32,400
+23,400
+260% +$2.71M ﹤0.01% 1328
2022
Q3 		$994K Buy
9,000
+6,600
+275% +$665K ﹤0.01% 2642
2022
Q2 		$179K Sell
2,400
-7,400
-76% -$544K ﹤0.01% 4750
2022
Q1 		$765K Sell
9,800
-57,900
-86% -$4.43M ﹤0.01% 3264
2021
Q4 		$6.1M Buy
67,700
+29,500
+77% +$2.52M 0.01% 1087
2021
Q3 		$2.99M Hold
38,200
– – ﹤0.01% 1675
2021
Q2 		$2.97M Buy
+38,200
New +$2.9M ﹤0.01% 1686
2021
Q1 		– Sell
-950
Closed -$16.2M – 9961
2020
Q4 		$16.2M Buy
950
+566
+147% +$83.9K 0.02% 411
2020
Q3 		$5.39M Buy
384
+143
+59% +$21.7K 0.01% 824
2020
Q2 		$3.86M Buy
241
+16
+7% +$2.18K 0.01% 1019
2020
Q1 		$2.2M Sell
225
-953
-81% -$109K ﹤0.01% 1214
2019
Q4 		$15.2M Buy
1,178
+160
+16% +$16.1K 0.03% 344
2019
Q3 		$7.67M Buy
1,018
+66
+7% +$7.79K 0.02% 506
2019
Q2 		$14.5M Buy
952
+125
+15% +$15.2K 0.04% 291
2019
Q1 		$9.86M Buy
827
+202
+32% +$26K 0.03% 399
2018
Q4 		$6.82M Buy
625
+290
+87% +$36.3K 0.02% 460
2018
Q3 		$5.41M Sell
335
-420
-56% -$57.4K 0.02% 579
2018
Q2 		$9.98M Buy
755
+680
+907% +$64.1K 0.04% 344
2018
Q1 		$12K Sell
75
-1,131
-94% -$75.4K ﹤0.01% 3884
2017
Q4 		$44K Buy
1,206
+218
+22% +$11.5K ﹤0.01% 2578
2017
Q3 		$192K Buy
988
+701
+244% +$28K 0.01% 1214
2017
Q2 		$185K Sell
287
-156
-35% -$5.08K 0.01% 1242
2017
Q1 		$335K Sell
443
-491
-53% -$15.2K 0.01% 905
2016
Q4 		$460K Sell
934
-2,827
-75% -$114K 0.03% 589
2016
Q3 		$501K Buy
3,761
+91
+2% +$2.75K 0.03% 502
2016
Q2 		$806K Buy
3,670
+3,104
+548% +$57.5K 0.05% 351
2016
Q1 		$338K Buy
566
+50
+10% +$874 0.03% 597
2015
Q4 		$41K Buy
516
+302
+141% +$9.79K ﹤0.01% 2084
2015
Q3 		$98K Buy
214
+86
+67% +$2.92K 0.01% 1432
2015
Q2 		$64K Sell
128
-30
-19% -$613 0.01% 1516
2015
Q1 		$174K Sell
158
-45
-22% -$600 0.02% 787
2014
Q4 		$317K Buy
+203
New +$3.44K 0.04% 408

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's SRPT Position: Q3 2024 in Review

Simplex Trading sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 63,784 shares — an estimated $8.82M sold.

Simplex Trading first reported a position in SRPT in Q4 2014 and held it in 30 quarters. The position peaked at $10.1M in Q2 2024. 457 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

  • Simplex Trading reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 63,784 Sarepta Therapeutics shares in Q3 2024, an estimated $8.82M.
  • Simplex Trading first reported a position in Sarepta Therapeutics in Q4 2014 and held it in 30 quarters.
  • Simplex Trading's Sarepta Therapeutics position peaked at $10.1M in Q2 2024.
  • 457 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.